Elephas publishes peer-reviewed data in Cell Reports Medicine demonstrating elive™ platform’s immunotherapy response measurement

Study Demonstrates 93% Accuracy in Predicting Clinical Benefit and Highlights the Platform’s Potential to Enhance Clinical Decision Making